Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Corrigendum Free access | 10.1172/JCI151380

The multifaceted nature of HIV latency

Caroline Dufour, Pierre Gantner, Rémi Fromentin, and Nicolas Chomont

Find articles by Dufour, C. in: JCI | PubMed | Google Scholar

Find articles by Gantner, P. in: JCI | PubMed | Google Scholar

Find articles by Fromentin, R. in: JCI | PubMed | Google Scholar

Find articles by Chomont, N. in: JCI | PubMed | Google Scholar

Published June 1, 2021 - More info

Published in Volume 131, Issue 11 on June 1, 2021
J Clin Invest. 2021;131(11):e151380. https://doi.org/10.1172/JCI151380.
© 2021 American Society for Clinical Investigation
Published June 1, 2021 - Version history
View PDF

Related article:

The multifaceted nature of HIV latency
Caroline Dufour, … , Rémi Fromentin, Nicolas Chomont
Caroline Dufour, … , Rémi Fromentin, Nicolas Chomont
Review Series Article has an altmetric score of 43

The multifaceted nature of HIV latency

  • Text
  • PDF
Abstract

Although antiretroviral therapies (ARTs) potently inhibit HIV replication, they do not eradicate the virus. HIV persists in cellular and anatomical reservoirs that show minimal decay during ART. A large number of studies conducted during the past 20 years have shown that HIV persists in a small pool of cells harboring integrated and replication-competent viral genomes. The majority of these cells do not produce viral particles and constitute what is referred to as the latent reservoir of HIV infection. Therefore, although HIV is not considered as a typical latent virus, it can establish a state of nonproductive infection under rare circumstances, particularly in memory CD4+ T cells, which represent the main barrier to HIV eradication. While it was originally thought that the pool of latently infected cells was largely composed of cells harboring transcriptionally silent genomes, recent evidence indicates that several blocks contribute to the nonproductive state of these cells. Here, we describe the virological and immunological factors that play a role in the establishment and persistence of the pool of latently infected cells and review the current approaches aimed at eliminating the latent HIV reservoir.

Authors

Caroline Dufour, Pierre Gantner, Rémi Fromentin, Nicolas Chomont

×

Original citation: J Clin Invest. 2020;130(7):3381–3390. https://doi.org/10.1172/JCI136227

Citation for this corrigendum: J Clin Invest. 2021;131(11):e151380. https://doi.org/10.1172/JCI151380

The description of the effect of polypyrimidine tract–binding protein (PTB) on HIV RNA export was incorrect in the section Molecular mechanisms of HIV latency and in Figure 3.

The correct sentence is below.

Furthermore, viral RNAs accumulate in the nucleus of latently infected cells, and this defect in RNA export can be reverted by overexpressing the polypyrimidine tract–binding protein (PTB) in resting cells (39).

The text and Figure 3 have been updated in the HTML version and PDF with the correct information.

The authors regret the error.

Footnotes

See the related article at The multifaceted nature of HIV latency.

Version history
  • Version 1 (June 1, 2021): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 3 news outlets
Posted by 26 X users
On 1 Facebook pages
158 readers on Mendeley
See more details